This review summarizes recent advancements in the diagnosis and management of Long QT syndrome.
Answers are grounded in this paper and cite their sources.
Provides updated Long QT synthesis for clinicians; leaves open need for prospective validation of emerging strategies.
Long QT syndrome (LQTS) is a potentially life-threatening canalopathy, accompanied by prolonged QT interval on a 12-channel ECG, syncopal conditions and a high risk for sudden cardiac death due to the development of torsade de pointes (TdP) polymorphic ventricular tachycardia. The primary goal in management of patients with LQTS at the present stage is prevention of undiagnosed forms, adequate treatment and prophylaxis, facilitated by the rapid development of molecular biology and genetics. The second part of the present review reflects the latest achievements in its diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Kalatsei et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: